1 |
Sanyal S, Amin SA, Adhikari N, Jha T. Ligand-based design of anticancer MMP2 inhibitors: a review. Future Med Chem 2021;13:1987-2013. [PMID: 34634916 DOI: 10.4155/fmc-2021-0262] [Reference Citation Analysis]
|
2 |
Suay-Garcia B, Falcó A, Bueso-Bordils JI, Anton-Fos GM, Pérez-Gracia MT, Alemán-López PA. Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds Against Escherichia coli. Pharmaceuticals (Basel) 2020;13:E431. [PMID: 33260726 DOI: 10.3390/ph13120431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
3 |
Amin SA, Banerjee S, Adhikari N, Jha T. Discriminations of active from inactive HDAC8 inhibitors Part II: Bayesian classification study to find molecular fingerprints. SAR QSAR Environ Res 2020;31:245-60. [PMID: 32073312 DOI: 10.1080/1062936X.2020.1723136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
4 |
Reda Aouad M, Almehmadi MA, Faleh Albelwi F, Teleb M, Tageldin GN, Abu-serie MM, Hagar M, Rezki N. Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105816] [Reference Citation Analysis]
|
5 |
Das S, Amin SA, Gayen S, Jha T. Insight into the structural requirements of gelatinases (MMP-2 and MMP-9) inhibitors by multiple validated molecular modelling approaches: Part II. SAR QSAR Environ Res 2022;33:167-92. [PMID: 35301933 DOI: 10.1080/1062936X.2022.2041722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|